Prosecution Insights
Prosecution Insights
7 pending office actions • 6 art units • 6 examiners • 0 of 7 (0%) have an AI response strategy ready
Based on the USPTO statutory response window for each pending office action. 7 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 7 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (14%) |
| §112 only | 1 (14%) |
| No statute on record | 5 (71%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| KUCHARCZK, JED A | 2 | 80.2% | +15.6% |
| WHITE, DAWANNA SHAR-DAY | 1 | 62.3% | +24.5% |
| HABTE, KAHSAY | 1 | 84.9% | +7.3% |
| SEITZ, ANTHONY JOSEPH | 1 | 68.8% | +28.3% |
| DENT, ALANA HARRIS | 1 | 44.6% | +32.4% |
| OUSPENSKI, ILIA I | 1 | 77.6% | +20.3% |
Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18517894 | SALTS OF A PI3Kdelta INHIBITOR, CRYSTALLINE FORMS, METHODS OF PREPARATION, AND USES THEREFORE | HABTE, KAHSAY | 28d overdue |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 6 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18099319 | ORAL CAPSULE AND PREPARATION METHOD THEREFOR | KUCHARCZK, JED A | 132d overdue |
| 17617531 | ORAL CAPSULE AND PREPARATION METHOD THEREFOR | KUCHARCZK, JED A | 92d overdue |
| 18309700 | ANTI-PD1 ANTIBODIES AND THEIR USE AS THERAPEUTICS AND DIAGNOSTICS | OUSPENSKI, ILIA I | 59d overdue |
| 18524170 | Methods of Treating B-Cell Malignancy Using Bcl-2 Inhibitor | WHITE, DAWANNA SHAR-DAY | 14d |
| 18262236 | Methods of Cancer Treatment Using Anti-TIGIT Antibodies in Combination with Anti-PD1 Antibodies | DENT, ALANA HARRIS | 21d |
| 18263448 | METHODS OF TREATING CHRONIC ACTIVE ANTIBODY-MEDIATED REJECTION USING BTK INHIBITORS | SEITZ, ANTHONY JOSEPH | 29d |
| Art Unit | Apps |
|---|---|
| 1623 | 2 |
| 1627 | 1 |
| 1624 | 1 |
| 1629 | 1 |
| 1643 | 1 |
| 1644 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18524170 | Methods of Treating B-Cell Malignancy Using Bcl-2 Inhibitor | WHITE, DAWANNA SHAR-DAY | 1627 | Other | Non-Final OA | 14d | Pending | Nov 30, 2023 |
| 18517894 | SALTS OF A PI3Kdelta INHIBITOR, CRYSTALLINE FORMS, METHODS OF PREPARATION, AND USES THEREFORE | HABTE, KAHSAY | 1624 | §112 | Non-Final OA | 28d overdue | Pending | Nov 22, 2023 |
| 18263448 | METHODS OF TREATING CHRONIC ACTIVE ANTIBODY-MEDIATED REJECTION USING BTK INHIBITORS | SEITZ, ANTHONY JOSEPH | 1629 | §103 | Non-Final OA | 29d | Pending | Jul 28, 2023 |
| 18262236 | Methods of Cancer Treatment Using Anti-TIGIT Antibodies in Combination with Anti-PD1 Antibodies | DENT, ALANA HARRIS | 1643 | Other | Non-Final OA | 21d | Pending | Jul 20, 2023 |
| 18309700 | ANTI-PD1 ANTIBODIES AND THEIR USE AS THERAPEUTICS AND DIAGNOSTICS | OUSPENSKI, ILIA I | 1644 | Other | Non-Final OA | 59d overdue | Pending | Apr 28, 2023 |
| 18099319 | ORAL CAPSULE AND PREPARATION METHOD THEREFOR | KUCHARCZK, JED A | 1623 | — | Final Rejection | 132d overdue | Pending | Jan 20, 2023 |
| 17617531 | ORAL CAPSULE AND PREPARATION METHOD THEREFOR | KUCHARCZK, JED A | 1623 | Other | Final Rejection | 92d overdue | Pending | Dec 08, 2021 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial